The University of Chicago Header Logo

Connection

Kathryn Mills to Endometrial Neoplasms

This is a "connection" page, showing publications Kathryn Mills has written about Endometrial Neoplasms.
Connection Strength

1.470
  1. SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth. Gynecol Oncol. 2018 11; 151(2):337-344.
    View in: PubMed
    Score: 0.540
  2. Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer. Int J Gynecol Cancer. 2017 10; 27(8):1774-1782.
    View in: PubMed
    Score: 0.507
  3. Tumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancer. CA Cancer J Clin. 2022 03; 72(2):102-111.
    View in: PubMed
    Score: 0.171
  4. Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer. Gynecol Oncol. 2019 04; 153(1):123-126.
    View in: PubMed
    Score: 0.139
  5. Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy. PLoS One. 2016; 11(1):e0147145.
    View in: PubMed
    Score: 0.113
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.